PavmedPAVM
13F holders, Q2 2026 (June 30)19holders −1
4new positions
4sold out
$5.94avg. 13F price*
At the end of Q2 2026, 19 institutions reported holding Pavmed Inc. (PAVM) in their 13F filings, down 1 from Q1 2026. 4 opened new positions and 4 sold out. The largest holders were Two Seas Capital LP ($2.7M), First Manhattan Co. Llc. ($2.0M) and Vanguard Capital Management LLC ($366K).
- Company
- Pavmed Inc.
- CUSIP
- 70387R502
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $475 |
| Exits | 4 | $7K |
All 13F filers, Q1 2026 → Q2 2026: 424,628 shares bought and 707 shares sold, net +423,921 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| Two Seas Capital LP | 0.10% | No change | 461,539 | $2.7M |
| First Manhattan Co. Llc. | 0.01% | Add +1298.5% | 332,911 | $2.0M |
| Vanguard Capital Management LLC | 0.00% | Add +941.1% | 61,604 | $366K |
| Geode Capital Management, LLC | 0.00% | Add +211.4% | 36,678 | $218K |
| Vanguard Fiduciary Trust Co. | 0.00% | Add +371.6% | 25,605 | $152K |
| BlackRock, Inc. | 0.00% | Add +607.5% | 17,092 | $102K |
| Morgan Stanley | 0.00% | Reduce -1.2% | 163 | $968 |
| Barclays PLC | 0.00% | New | 75 | $446 |
| SBI Securities Co., Ltd. | 0.00% | No change | 67 | $398 |
| UBS Group AG | 0.00% | Reduce -24.0% | 57 | $339 |
| Wells Fargo & Company | 0.00% | No change | 45 | $267 |
| Allworth Financial LP | 0.00% | Reduce -16.7% | 5 | $30 |
| Federation des caisses Desjardins du Quebec | 0.00% | New | 4 | $23 |
| Osaic Holdings, Inc. | 0.00% | No change | 4 | $21 |
| Steward Partners Investment Advisory, LLC | 0.00% | Add +100.0% | 2 | $12 |
| BNP Paribas Financial Markets | 0.00% | No change | 1 | $6 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 1 | $6 |
| Jones Financial Companies LLLP | 0.00% | No change | 1 | $5 |
| Royal Bank of Canada | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is PAVM's weight in each manager's 13F, not the share of Pavmed Inc. the manager owns.